Company Search:
Advanced Search
Sponsored Links
Suda Pharmaceuticals Ltd Company Snapshot
Suda Pharmaceuticals Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Suda Pharmaceuticals Ltd with three other companies in this sector in AUSTRALIA : Patrys Limited (2020 sales of 772,844.00 Australian Dollars [US$595,414.47 ] ), Biotron Limited (803,026.00 Australian Dollars [US$618,667.29 ] of which 100% was Biomedical Industry), and Living Cell Technologies Ltd (553,692.00 Australian Dollars [US$426,575.39 ] of which 100% was Research and Development).

Sales Analysis. During the second fiscal quarter of 2021, sales at Suda Pharmaceuticals Ltd totalled A$246,069.00 . This is a drop of 35.9% from the A$383,891.00 in sales at the company during the second quarter in 2020. Suda Pharmaceuticals Ltd reported sales of A$576,203.00 (US$443.92 thousand) for the fiscal year ending June of 2020. This represents a sharp decrease of 53.9% versus 2019, when the company's sales were A$1.25 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Suda Pharmaceuticals Ltd
  Stock Performance Chart for Suda Pharmaceuticals Ltd
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): .04
(Figures in Australian Dollars)
1 Week -4.4%   13 Weeks 22.9%  
4 Weeks 0.0%   52 Weeks n/a  
Suda Pharmaceuticals Ltd Key Data:
  Ticker: SUD Country: Australia
  Exchanges: FRA OTC ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 576,203
(Year Ending Jan 2021).
Employees: 44
  Currency: Australian Dollars Market Cap: 16,492,430
  Fiscal Yr Ends: June Shares Outstanding: 383,544,877
  Share Type: Ordinary Closely Held Shares: 63,415,845
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.